Atasever Ayse Gulsah, Ozcan Perihan Ergin, Kasali Kamber, Abdullah Taner, Orhun Gunseli, Senturk Evren
Anesthesiology and Intensive Care, Sinop Ayancik State Hospital, Sinop, Turkey.
Anesthesiology and Intensive Care, Istanbul University Hospital, Istanbul, Turkey.
Ther Clin Risk Manag. 2018 Feb 23;14:385-391. doi: 10.2147/TCRM.S158492. eCollection 2018.
Gastrointestinal (GI) motility disorders in intensive care patients remain relatively unexplored. Nowadays, the frequency, risk factors and complications of GI dysfunction during enteral nutrition (EN) become more questionable.
To evaluate the frequency, risk factors and complications of GI dysfunction during EN in the first 2 weeks of the intensive care unit (ICU) stay and to identify precautions to prevent the development of GI dysfunction and avoid complications.
In this prospective observational study, we deliberately targeted at-risk patients. A total of 137 patients who received nasogastric tube feeding in an ICU of a tertiary hospital were enrolled.
The incidence of GI dysfunction that was found to be 63% which was associated mainly between MDR bacteria positivity and negative fluid balance. Diarrhea was observed in 36 patients (26%) and on 147 patient-days (incidence rate, 5.5 per 100 patient-days). The median day of diarrhea onset was 6 days after the initiation of EN. Forty patients (29%) presented with constipation (85% during the first week). Fifty patients (36%) exhibited upper digestive intolerance on 212 patient-days (incidence rate, 7.9 per 100 patient-days), after a median EN duration of 6 days (range, 2-14 days). Logistic regression analysis revealed MDR bacteria growth in the culture (OR, 1.75; 95% CI, 1.15-2.67; =0.008) and negative fluid balance (OR, 0.57; 95% CI, 0.34-0.94; =0.03) as the risk factors for GI dysfunction. We also showed that GI dysfunction was associated with high SOFA score, hypoalbuminemia, catecholamine use, and prolonged length of stay (LOS). GI dysfunction, on the other hand, can cause some complications including inadequate nutrition, and newly developed decubitus ulcers.
GI dysfunction should be considered a clinical predictor of inadequate nutrition and prolonged LOS. In addition, the most dramatic risk for GI dysfunction was observed in patients with MDR bacteria growth in the culture and patients in negative fluid balance. Intensivists provide appropriate nutrition for patients, as well as prompt intervention and the development of treatment strategies in the event of GI dysfunction.
重症监护患者的胃肠动力障碍仍相对未被充分研究。如今,肠内营养(EN)期间胃肠功能障碍的发生率、危险因素及并发症更令人质疑。
评估重症监护病房(ICU)住院前2周EN期间胃肠功能障碍的发生率、危险因素及并发症,并确定预防胃肠功能障碍发生及避免并发症的预防措施。
在这项前瞻性观察研究中,我们特意针对有风险的患者。共有137例在一家三级医院ICU接受鼻胃管喂养的患者入组。
发现胃肠功能障碍的发生率为63%,主要与多重耐药菌阳性和液体负平衡有关。36例患者(26%)出现腹泻,共147个患者日(发生率为每100个患者日5.5次)。腹泻开始的中位天数为EN开始后6天。40例患者(29%)出现便秘(85%发生在第一周)。50例患者(36%)在212个患者日出现上消化道不耐受(发生率为每100个患者日7.9次),EN中位持续时间为6天(范围2 - 14天)。逻辑回归分析显示培养物中多重耐药菌生长(比值比,1.75;95%置信区间,1.15 - 2.67;P = 0.008)和液体负平衡(比值比,0.57;95%置信区间,0.34 - 0.94;P = 0.03)是胃肠功能障碍的危险因素。我们还表明胃肠功能障碍与高序贯器官衰竭评估(SOFA)评分、低白蛋白血症、儿茶酚胺使用及住院时间延长有关。另一方面,胃肠功能障碍可导致一些并发症,包括营养不足和新出现的压疮。
胃肠功能障碍应被视为营养不足和住院时间延长的临床预测指标。此外,在培养物中多重耐药菌生长的患者和处于液体负平衡的患者中观察到胃肠功能障碍的风险最为显著。重症监护医生应为患者提供适当营养,以及在发生胃肠功能障碍时及时干预并制定治疗策略。